Healthcare Value Capital as of June 30, 2017
Portfolio Holdings for Healthcare Value Capital
Healthcare Value Capital holds 13 positions in its portfolio as reported in the June 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Gilead Sciences Call Option (GILD) | 17.2 | $9.6M | 135k | 70.78 | |
| Pfizer (PFE) | 15.1 | $8.4M | 250k | 33.59 | |
| Novelion Therapeutics Com New | 13.8 | $7.7M | 831k | 9.23 | |
| DepoMed Call Option | 12.5 | $7.0M | 650k | 10.74 | |
| Proshares Tr Ultsh Nasd Biot | 9.8 | $5.5M | 225k | 24.24 | |
| CryoLife Put Option (AORT) | 7.2 | $4.0M | 200k | 19.95 | |
| Allergan SHS | 6.6 | $3.6M | 15k | 243.07 | |
| Proshares Tr Ii Vix Short Term F Call Option | 4.8 | $2.7M | 250k | 10.63 | |
| Teva Pharmaceutical Inds Sponsored Adr (TEVA) | 4.5 | $2.5M | 75k | 33.23 | |
| D Fluidigm Corp Del Call Option (LAB) | 3.7 | $2.1M | 511k | 4.04 | |
| Amarin Corp Spons Adr New (AMRN) | 3.3 | $1.8M | 450k | 4.03 | |
| Immunomedics Call Option | 1.6 | $883k | 100k | 8.83 | |
| Fibrocell Science Com Par Call Option | 0.1 | $40k | 10k | 4.00 |
